Skip to main content
Clinical Trials/NCT03308851
NCT03308851TerminatedNot Applicable

Evaluation of the Effects of Osteoperforation and Piezocorticision on Canine Retraction: Randomized Controlled Clinical Trial.

Université de Montréal1 site in 1 country17 target enrollmentStarted: January 1, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
17
Locations
1
Primary Endpoint
Rate of canine retraction

Study Overview

Brief Summary

The primary objective of this research is to compare the rate of canine retraction following the osteoperforation and piezocorticision procedures in cases of first premolar extractions. The secondary objectives are to compare the second order movement of the canine (tipping), the amount of root resorption associated with the procedures, the inflammation process by measuring the inflammatory markers in the gingival crevicular fluid, the loss of posterior anchorage by measures on the cone beam computed tomography (CBCT) 3-dimensional radiograph and on the casts and to evaluate the pain level and the impact on quality of life following each procedure using the questionnaire of the visual analogue scale (VAS) of pain.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
16 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Dental and/or skeletal Cl I and II requiring maxillary first premolar extraction.
  • •Young adults 16 years and older.
  • •Good overall health.
  • •Complete adult dentition.
  • •Cooperative.
  • •Acceptable hygiene.
  • •Absence of any periodontal disease (gingivitis, periodontitis).

Exclusion Criteria

  • •Non-cooperative, fearful patients or patients with intellectual disability.
  • •Patients requiring the regular use of nonsteroidal anti-inflammatory drugs (NSAID).
  • •Use of antibiotics in the last 6 months.
  • •Previous or current use of bisphosphonates, corticosteroids or immunosuppressive drugs.
  • •Patients suffering from uncontrolled systemic diseases (ex. diabetes type I and II).
  • •Presence of oral or maxillofacial malformations (ex. cleft palate) or dental pathologies (ex. ankylosis, abscess).

Arms & Interventions

Piezocorticision and osteoperforation group

Experimental

All participants in this arm will receive the piezocorticision and osteoperforation procedures on the upper jaw on the left and the right side.

Intervention: Piezocorticision (Procedure)

Control

No Intervention

The participants in this arm will receive no treatment, but will have the same monitoring as the experimental group.

Piezocorticision and osteoperforation group

Experimental

All participants in this arm will receive the piezocorticision and osteoperforation procedures on the upper jaw on the left and the right side.

Intervention: Osteoperforation (Procedure)

Outcomes

Primary Outcomes

Rate of canine retraction

Time Frame: From the time of force application until the distal of the canine touches the mesial of the second premolar. We estimate the time frame to be up to 24 weeks. Measures will be taken at two week intervals.

The speed at which the canine is moved in the space of the extracted premolar.

Secondary Outcomes

  • Concentration of osteoprotegerin (OPG) in the gingival fluid sample(Measures are taken immediately before the periodontal procedures, then at 1,3,8 weeks and when the distal of the canine touches the mesial surface of the second premolar which can take up to 24 weeks.)
  • Level of pain(Daily, for 7 days following extraction of premolars and piezocorticision and osteoperforation procedures)
  • Concentration of IL-1 in the gingival fluid sample(Measures are taken immediately before the periodontal procedures, then at 1,3,8 weeks and when the distal of the canine touches the mesial surface of the second premolar which can take up to 24 weeks.)
  • Amount of tipping(The measure is taken when the distal of the canine touches the mesial of the second premolar. We estimate the time frame to be up to 24 weeks)
  • Amount of root resorption(The measure is taken when the distal of the canine touches the mesial of the second premolar. We estimate the time frame to be up to 24 weeks)
  • Amount of posterior loss of anchorage(The measure is taken when the distal of the canine touches the mesial of the second premolar. We estimate the time frame to be up to 24 weeks)
  • Concentration of receptor activator of nuclear factor kappa-B ligand (RANKL) in the gingival fluid sample(Measures are taken immediately before the periodontal procedures, then at 1,3,8 weeks and when the distal of the canine touches the mesial surface of the second premolar which can take up to 24 weeks.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Le George Dinh-Khang

Principal investigator

Université de Montréal

Study Sites (1)

Loading locations...

Similar Trials